Reply to "Rigor, reproducibility and in vitro CSF assays: The devil in the details"

Yves Dauvilliers^{1

2}, Pierre Charnet³

Affiliations

¹ Department of Neurology, National Reference Network for Narcolepsy, Hôpital Gui-de-Chauliac, CHU Montpellier, Montpellier, France.
² Inserm, U1061, Montpellier, France; Université Montpellier, Montpellier, France.
³ IBMM CNRS UMR 5247, Université Montpellier, France.

Comment

Yves Dauvilliers et al. Ann Neurol. 2017 Jun.

. 2017 Jun;81(6):907-910.

doi: 10.1002/ana.24939. Epub 2017 Jun 2.

Yves Dauvilliers^{1

2}, Pierre Charnet³

¹ Department of Neurology, National Reference Network for Narcolepsy, Hôpital Gui-de-Chauliac, CHU Montpellier, Montpellier, France.
² Inserm, U1061, Montpellier, France; Université Montpellier, Montpellier, France.
³ IBMM CNRS UMR 5247, Université Montpellier, France.

No abstract available

Comment on

Absence of γ-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders.
Dauvilliers Y, Evangelista E, Lopez R, Barateau L, Jaussent I, Cens T, Rousset M, Charnet P. Dauvilliers Y, et al. Ann Neurol. 2016 Aug;80(2):259-68. doi: 10.1002/ana.24710. Epub 2016 Jul 14. Ann Neurol. 2016. PMID: 27315195
Rigor, reproducibility, and in vitro cerebrospinal fluid assays: The devil in the details.
Moody OA, Talwar S, Jenkins MA, Freeman AA, Trotti LM, García PS, Bliwise D, Lynch JW, Cherson B, Hernandez EM, Feldman N, Saini P, Rye DB, Jenkins A. Moody OA, et al. Ann Neurol. 2017 Jun;81(6):904-907. doi: 10.1002/ana.24940. Epub 2017 Jun 1. Ann Neurol. 2017. PMID: 28440033 Free PMC article.